We are glad to kick off the 2022 with a success story: the Cluster Management was awarded with both the GOLD Label of the European Cluster Excellence Initiative (ECEI) and the “Cluster-Exzellenz Baden-Württemberg” Quality Label for its high level of professionalism and advanced cluster management. These Labels show the Cluster’s commitment towards continuous improvement of their structures and routines for the benefit of all cluster members and the entire region, contributing to the development of a new lead industry Baden-Württemberg. [more]
Have a look also to a recent article, published in the IHK Magazin, where Julia Schaft shared BioRN vision to accelerate innovation in biotech through BioLabs, a premium, fully-equipped laboratory and office space with unparalleled access to capital and industry partners. The article highlights the huge potential of Heidelberg, as one of the most innovative and dynamic City in Europe! (in German [more])
Join us tomorrow at 11 am for the kick-off of the BioRN Espresso Series: SAMPLES and DATA to improve healthcare: Value - Potential - Challenges. The event is digital and will taggle the different perspectives and main issues in accessing patient data and samples. [more]
CALL for Startups: AbbVie and Sanofi are currently granting Golden Tickets for early-stage biotech company, including the opportunity for residence in Biolabs Heidelberg. Do not miss this unique opportunity!
And finally, in case you have missed one of my previous email, you can download it here our BioRN Events Calendar. Sync it with yours!
Enjoy the read!
Annalisa Zuccotti
Events & Communication Lead
BioRN Life Science Cluster Rhine-Neckar
01 | Research Highlights & News
02 | BioRN Lounge
03 | BioRN Espresso series from February 2022
04 | Funding - Research Grants
05 | Event Calendar & Discounts
06 | Open Positions
01| Research Highlights & News
BioRN: Spotlight on the Heidelberg economy and the Biotech Innovation Park [more]
Apogenix Receives €20.7 Million in Public Funding [more]
BIO Deutschland: Biotech industry: many investments, minor momentum from change of government [more]
btS e.V.: Award for ScieMatch platform for company matchmaking [more]
SAMPLES and DATA to improve healthcare: Value - Potential - Challenges
On February 1 at 11 am
"Access to patient data and samples: Different perspectives and main issues"
with Peter Schirmacher - Director of the Institute of Pathology - Heidelberg University Hospital
Andreas Schmidt - CEO - Proteona
Philipp Mann - Senior Partnership Manager - Owkin
BMBF - Alternative methods to animal testing[more] EU4Health 2021-2027 - a vision for a healthier Europe[more] European Innovation Council EIC launched:
You are currently viewing a placeholder content from Mailchimp. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
